Cairo-Mubasher: Birzeit Pharmaceuticals Co shareholders approved a cash dividend representing 17% of the nominal value to be distributed on 1 May 2015.

The company reported a drop in net profit after taxes by 23.2% to $4.2 million in 2014, compared to $5.5 million in 2013.

The Palestine-listed firm’s capital amounts to $13 million, distributed on 13 million shares at $1 par value each.